Business
British regulators asked to assess AstraZeneca-Oxford COVID-19 vaccine, as new trial looks into lower dosage – ABC News
The British Government formally asks its medicines regulator to assess whether the AstraZeneca-Oxford COVID-19 vaccine should be authorised for use as the vaccine’s…
The British Government has formally asked its medicines regulator to assess whether a coronavirus vaccine developed by drug company AstraZeneca and Oxford University should be authorised for use.
It comes as AstraZeneca said it plans to conduct a new global clinical trial to assess the vaccine’s efficacy.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency to determine whether the vaccine “meets rigorous safety standards.”
Here’s the latest…
-
Business20 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News20 hours agoBrisbane’s 2025–26 budget revealed: rate hikes, service fee rises and major infrastructure plans
-
General14 hours agoActivism under the guise of good intentions
-
Noosa News14 hours agoHow errors, penalties and bad decisions helped New South Wales beat themselves in Origin II